ShareholdingJul 22, 2026, 12:03 PM
OKYO Pharma Chairman Increases Stake to 20.55% with $32.6K Purchase
AI Summary
OKYO Pharma announced that its Chairman, Gabriele Cerrone, increased his stake in the company. Through Panetta Partners Ltd, he purchased 22,500 ordinary shares at $1.45 each, totaling $32,625. This transaction brings his total holding to 10,873,916 ordinary shares, representing 20.55% of the issued share capital. OKYO Pharma is a clinical-stage biopharmaceutical company developing therapies for neuropathic corneal pain and plans to initiate a Phase 3 clinical trial for urcosimod later this year.
Key Highlights
- Chairman Gabriele Cerrone, through Panetta Partners Ltd, increased his holdings.
- Purchased 22,500 ordinary shares at $1.45 per share.
- Total purchase value was $32,625.
- His total holding is now 10,873,916 ordinary shares.
- This represents 20.55% of OKYO Pharma's issued share capital.
- OKYO Pharma is a clinical-stage biopharmaceutical company.
- Company plans to initiate a global Phase 3 pivotal clinical trial for urcosimod.
Price Impact
More from OKYO